Evofem Biosciences

Evofem is a California-based biopharmaceutical company that develops and commercializes contraceptive products for the treatment of reproductive disorders in women.

Business Model:

Revenue: $20.2M

Employees: 51-200

Detailed Evofem Biosciences Information

Geographic Data

Evofem Biosciences headquarters map

Address: 12400 High Bluff Drive

City: San Diego

State: CA

Zip: 92130

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$27M

Raised Total:

$288M

Metrics

1,197,073Website Global Rank

25,481Website Monthly Traffic

Twitter Followers

Description

Evofem is a California-based biopharmaceutical company that develops and commercializes contraceptive products for the treatment of reproductive disorders in women.

Contact Phone:
+18585501900

Contact Email:

Evofem Biosciences went public on 11/21/2014 on the OTCMKTS

Listed Exchange:
OTCMKTS

IPO Date:
11/21/2014

Ticker Symbol:
EVFM

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2022 Equity $2.3M
12/2012 Series C 6 $20.6M RUSNANO
RMI Partners
Numoda Capital Innovations
Domain Associates
AMOREPACIFIC Ventures
Alta Partners
RUSNANO
RMI Partners
Numoda Capital Innovations
Domain Associates
AMOREPACIFIC Ventures
Alta Partners
6/2019 Post-IPO Equity $0 PDL Biopharma
PDL Biopharma
PDL Biopharma
PDL Biopharma
12/2009 Venture Round $25M
5/2021 Post-IPO Equity $50M
7/2013 Series C 2 $6.7M RUSNANO
Mirae Asset Venture Investment
RUSNANO
Mirae Asset Venture Investment
2/2014 Series C 3 $8M Domain Associates
Alta Partners
AKS Capital
Domain Associates
Alta Partners
AKS Capital
10/2020 Post-IPO Debt 1 $25M Adjuvant Capital
Adjuvant Capital
Adjuvant Capital
Adjuvant Capital
5/2022 Post-IPO Equity $26.6M
4/2019 Post-IPO Equity $0 PDL Biopharma
PDL Biopharma
PDL Biopharma
PDL Biopharma
11/2015 Post-IPO Equity $20M
8/2017 Post-IPO Equity $7.5M
3/2021 Post-IPO Equity $30M
6/2020 Post-IPO Equity $100M
5/2018 Post-IPO Equity $36.4M
10/2021 Series B 1 $10M Keystone Capital
Keystone Capital
8/2016 Post-IPO Equity 1 $25M Woodford Investment Management
Woodford Investment Management
6/2019 Post-IPO Equity 1 $50M PDL Biopharma
PDL Biopharma
PDL Biopharma
PDL Biopharma
4/2019 Post-IPO Equity 1 $30M PDL Biopharma
PDL Biopharma
PDL Biopharma
PDL Biopharma
Announced Date Name Price
1/2018 Neothetics

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research